AI Verdict
ESNT has stronger fundamentals based on our AI analysis.
ESPR vs ESNT Fundamental Comparison
| Metric | ESPR | ESNT |
|---|---|---|
| Revenue | $403.1M | $1.3B |
| Net Income | $-22.7M | $690.0M |
| Net Margin | -5.6% | 54.7% |
| ROE | N/A | 12.0% |
| ROA | -4.9% | 9.3% |
| Current Ratio | 1.54x | N/A |
| Debt/Equity | N/A | 0.07x |
| EPS | $-0.11 | $6.90 |
Green = Better metric | Red = Weaker metric
You Might Also Compare
ESPR vs ESNT: Frequently Asked Questions
Is ESPR or ESNT a better buy in 2026?
Based on dual AI fundamental analysis (Claude and ChatGPT), ESNT has stronger fundamentals. ESPR is rated SELL (78% confidence) while ESNT is rated STRONG BUY (88% confidence). This is not investment advice.
How does ESPR compare to ESNT fundamentally?
Esperion Therapeutics, Inc. has ROE of N/A vs Essent Group Ltd.'s 12.0%. Net margins are -5.6% vs 54.7% respectively.
Which stock pays higher dividends, ESPR or ESNT?
ESPR has a dividend yield of N/A or no dividend while ESNT has N/A or no dividend. Check individual stock pages for detailed dividend history and payout ratios.
Should I invest in ESPR or ESNT for long term?
For long-term investing, consider that ESPR has SELL rating with 78% confidence, while ESNT has STRONG BUY rating with 88% confidence. Higher confidence indicates more consistent fundamentals from SEC filings. This is not investment advice - always do your own research.
What do the AI models say about ESPR vs ESNT?
Our dual AI system (Claude by Anthropic and ChatGPT by OpenAI) analyzes SEC 10-K and 10-Q filings independently. For ESPR vs ESNT, the AI consensus favors ESNT based on fundamental metrics including revenue growth, profitability, ROE, and balance sheet strength.